Reduced levels of a metabolic hormone known as leptin, largely produced by fat tissue, is linked to poor vaccine antibod...
CEPI, the Coalition for Epidemic Preparedness Innovations, and SK bioscience have announced an expanded partnership to d...
The Health Sciences Authority (HSA) in Singapore has approved the new storage condition for the Pfizer-BioNTech COVID-19...
CanSino Biologics Inc has announced that its recombinant novel coronavirus vaccine, (Adenovirus Type 5 Vector) (‘A...
Novavax, Inc., a US-based biotechnology company developing next-generation vaccines for serious infectious diseases, has...
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Panacea Biotec, one of the leading v...
Last month was World Immunization Week and never has it been a more pertinent milestone. It has been 13 months since the...
The Health Sciences Authority (HSA) at Singapore has extended the authorisation of Pfizer-BioNTech COVID-19 vaccine for ...
A single-dose vaccine that targets new COVID-19 variants has been awarded funding to fast-track testing in human trials....
Moderna, Inc., has announced a new supply agreement with the government of Australia for 25 million doses. Thi...
Shanghai Fosun Pharma has signed a Joint Venture with BioNTech to manufacture mRNA vaccine in China. The JV will ha...
The European Commission has approved a contract for 1.8 billion doses of the BioNTech/Pfizer vaccine. The contract cove...
The U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) for the Pfizer-BioNTech C...
The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national science agency, has...
COVID-19 infections continue to rise with several countries facing second-and third-wave infections with the newly evolv...
The World Health Organisation (WHO) has listed the Sinopharm COVID-19 vaccine for emergency use, giving the green light ...
A malaria vaccine created by scientists at the University of Oxford’s Jenner Institute has been found to be 77% ef...
Moderna, Inc., a US based biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced...
